STIM News and Press, Neuronetics Inc. From 05/07/24

Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...

2024-05-06 11:06:36 ET More on Neuronetics Neuronetics, Inc. (STIM) Q4 2023 Earnings Call Transcript Neuronetics gets FDA nod for NeuroStar as add-on treatment for adolescents with depression Neuronetics announces 5-year exclusive partnership with TCN Seeking...

MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) --  Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is committed to supporting adolescents ...

MALVERN, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that it plans to release first qu...

MALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced the publication of significan...

2024-03-25 09:14:50 ET More on Neuronetics Neuronetics, Inc. (STIM) Q4 2023 Earnings Call Transcript Neuronetics: Modest Improvements Are Not Enough Neuronetics announces 5-year exclusive partnership with TCN Neuronetics expects preliminary Q4 revenue to be o...

MALVERN, Pa., March 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced clearance from the U.S. Food and ...

2024-03-07 08:56:49 ET More on Neuronetics Neuronetics, Inc. (STIM) Q4 2023 Earnings Call Transcript Neuronetics: Modest Improvements Are Not Enough Neuronetics expects preliminary Q4 revenue to be over $20M Seeking Alpha’s Quant Rating on Neuronetics ...

MALVERN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced an expanded commercial partnershi...

2024-03-05 12:19:09 ET Neuronetics, Inc. (STIM) Q4 2023 Earnings Conference Call March 5, 2024 08:30 a.m. ET Company Participants Keith Sullivan - President, Chief Executive Officer Steve Furlong - Chief Financial Officer Mark Klausner - Investor Relations ...